Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Education & Training

  • Fellowship Program, Pediatric Hematology/Oncology, 2002
    Johns Hopkins Hospital
  • ScM, 2001
    Johns Hopkins School of Public Health
  • Residency Program, Pediatrics, 1999
    Johns Hopkins Hospital
  • Internship Program, Pediatrics, 1997
    Johns Hopkins Hospital
  • MD, 1996
    Tufts University School of Medicine
  • BS, 1992
    Yale University

Board Certifications

  • American Board of Pediatrics
  • American Board of Pediatrics/Hematology-Oncology

Awards & Recognition

  • Top Doctors No Va Magazine (2016, 2015)

National Provider ID: 1346200250


David Jacobsohn, M.D., ScM, Division Chief of Blood and Marrow Transplantation, joined Children's National Health System from Children’s Memorial Hospital in Chicago, where he served as a member of the Stem Cell Transplant Program staff and as the Director of the Chronic Graft-versus-Host Disease Clinic. He has lectured widely on GvHD/BMT in Europe, Latin America, and the United States. Dr. Jacobsohn obtained a Bachelor of Science from Yale University, his medical degree from Tufts University, and a Masters in Clinical Investigation from Johns Hopkins School of Hygiene and Public Health.

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

Outside Interests

  • Therakos 

Acute graft versus host disease in children

(2008) Bone Marrow Transplantation

Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium

(2012) Blood

Early elevation of Creactive protein correlates with severe infection and nonrelapse mortality in children undergoing allogeneic stem cell transplantation

(2010) Biol Blood Marrow Transplant

Evaluation of pentostatin in cortico steroid refractory chronic graft versus host disease in children a Pediatric Blood and Marrow Transplant Consortium study

(2009) Blood

Favorable outcome for infant acute lymphoblastic leukemia following hematopoietic stem cell transplantation

(2005) Biology of Blood and Marrow Transplantation

Optimal management of chronic graft versus host disease in children

(2010) Br J Haematol

Phase II study of pentostatin in patients with cortico steroid refractory chronic graft versus host disease

(2007) J Clin Oncol

Reduced intensity hematopoietic stem cell transplantation for treatment of nonmalignant diseases in children

(2004) Lancet

Skin response using NIH consensus criteria versus Hopkins scale in a Phase II study for steroid refractory chronic GVHD

(2009) Bone Marrow Transplantation

Weight loss and reduced body mass index a critical issue in children with multiorgan chronic graft versus host disease

(2006) Bone Marrow Transplantation